Genentech: Medicines: Boniva
Links shared publicly online about this topic.
- 692total visits
Genentech: Medicines: Boniva
gene.com —
View full resource at gene.com
Tags: Osteoporosis Medication, Boniva, Genentech
Most Recently Shared on November 29, 2010 at 2:57 pm By:
Boniva Package Insert - more information about Boniva http://www.gene.com/gene/products/information/boniva/
FDA approves first Boniva generics to treat or prevent osteoporosis - - ModernMedicine
modernmedicine.com — “FDA approved the first generic versions of Boniva (ibandronate) tablets, a once-monthly product to treat or prevent osteoporosis in women after menopause” View full resource at modernmedicine.com
Most Recently Shared on March 24, 2012 at 5:12 am By:
FDA approves first Boniva generics to treat or prevent osteoporosis: FDA approved the first generic versions of ... http://t.co/WOufTBpE
Cell - Redefining Clinical Trials: The Age of Personalized Medicine
cell.com — “Cell - Redefining Clinical Trials: The Age of Personalized Medicine” View full resource at cell.com
Most Recently Shared on March 21, 2012 at 3:31 pm By:
Genentech VPs Lutzker & Mellman on Redefining #ClinicalTrials: The Age of Personalized #Medicine | via @CellCellPress http://t.co/cv3U4xaX
FDA Approves New Skin Cancer Drug | Healthland | TIME.com
healthland.time.com — “Federal regulators on Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma. The pill is called Erivedge and is made by Genentech, a unit of Swiss drugmaker Roche.” View full resource at healthland.time.com
Most Recently Shared on January 31, 2012 at 2:28 pm By:
FasterCures Health Organization
FDA ahead of schedule: 6-month review brings to market 1st drug to treat advanced basal cell carcinoma http://t.co/nm1SNrKd
Genentech: Newsroom: Press Releases: News Release January 30, 2012
gene.com — “Genentech News Release - FDA Approves Erivedge (Vismodegib) Capsule, the First Medicine for Adults with Advanced Basal Cell Carcinoma” View full resource at gene.com
Most Recently Shared on January 30, 2012 at 4:13 pm By:
New #Genentech medicine is 1st #FDA - approved medicine for adults w/ advanced basal cell carcinoma http://t.co/p4EDeaNB
Genentech: Newsroom: Press Releases: News Release November 5, 2011
gene.com — “Genentech: Newsroom: Press Releases: News Release November 5, 2011” View full resource at gene.com
Most Recently Shared on November 5, 2011 at 9:12 pm By:
Data presented at ACR showed Genentech medicine significantly improved signs and symptoms of rheumatoid arthritis. http://t.co/T9lWZobb
Genentech: Newsroom: Press Releases: News Release October 19, 2011
gene.com — “Genentech: Newsroom: Press Releases: News Release October 19, 2011” View full resource at gene.com
Most Recently Shared on October 20, 2011 at 5:02 am By:
Data at ECTRIMS showed Genentech medicine maintained reduction in disease activity for MS patients through 96 weeks. http://t.co/Zny5vapk
Genentech: Newsroom: Press Releases: News Release September 24, 2011
gene.com — “Genentech: Newsroom: Press Releases: News Release September 24, 2011” View full resource at gene.com
Most Recently Shared on September 24, 2011 at 10:04 pm By:
Genentech investigational medicine improved PFS & safety in HER2+ metastatic breast cancer; Abstract 5001 #EMCC2011 http://t.co/DC37sfeA
ECCO- European Cancer Organisation
stockholm2011.ecco-org.eu — “ECCO- European Cancer Organisation” View full resource at stockholm2011.ecco-org.eu
Most Recently Shared on September 23, 2011 at 4:01 pm By:
Genentech medicines featured in oral presentations at #EMCC2011 this weekend. http://t.co/9bv2R9QJ
How Roche Took Taxpayers for $1.4B by Charging $2,000 for Drugs That Could Cost $7 | BNET
bnet.com — “An IOG report brings together several years of research that Roche and Genentech would rather no one know about.” View full resource at bnet.com
Most Recently Shared on September 7, 2011 at 8:37 pm By:
Jim Edwards Health Communicator
How Roche Took Taxpayers for $1.4B by Charging $2,000 for Drugs That Could Cost $7: An IOG report brings t... http://t.co/ogxtznm
Genentech: Newsroom: FDA Approves New Personalized Medicine
gene.com — “Genentech: Newsroom: FDA Approves New Personalized Medicine” View full resource at gene.com
Most Recently Shared on August 17, 2011 at 5:19 pm By:
More information and materials for reporters available on Genentech’s Zelboraf http://t.co/KfYSIQP
Genentech: Newsroom: Press Releases: News Release August 17, 2011
gene.com — “Genentech: Newsroom: Press Releases: News Release August 17, 2011” View full resource at gene.com
Most Recently Shared on August 17, 2011 at 1:44 pm By:
Coping with Cancer Health Magazine
FDA Approves Zelboraf and Companion Diagnostic for BRAF Mutation-Positive Metastatic Melanoma http://t.co/4jc60WL
Tamiflu for oral suspension label revised, reflects new concentration - - ModernMedicine
modernmedicine.com — “The concentration of the influenza drug oseltamivir phosphate (Tamiflu, Genentech) for oral suspension has been reduced from 12 mg/mL to 6 mg/mL to reduce the possibility of prescribing and dosing confusion that can lead to medication errors, according to FDA.” View full resource at modernmedicine.com
Most Recently Shared on July 21, 2011 at 9:09 pm By:
Tamiflu for oral suspension label revised, reflects new concentration: The concentration of the influenza drug o... http://bit.ly/qV5Ifd
Genentech: Newsroom: Press Releases: News Release July 14, 2011
gene.com — “Genentech: Newsroom: Press Releases: News Release July 14, 2011” View full resource at gene.com
Most Recently Shared on July 15, 2011 at 5:03 am By:
Ph 3 study of Genentech investigational medicine in metastatic breast cancer meets primary endpoint. http://t.co/5hZy4rp
Spoonful of Medicine: Avastin for breast cancer unanimously overturned by FDA, but Genentech will continue to fight
blogs.nature.com — “Spoonful of Medicine: Avastin for breast cancer unanimously overturned by FDA, but Genentech will continue to fight” View full resource at blogs.nature.com
Most Recently Shared on June 30, 2011 at 7:25 pm By:
Nature Medicine Science Enthusiast
Avastin for breast cancer unanimously overturned by FDA, but Genentech will continue to fight http://ff.im/-GZkQx
Genentech: Newsroom: Press Releases: News Release June 29, 2011
gene.com — “Genentech: Newsroom: Press Releases: News Release June 29, 2011” View full resource at gene.com
Most Recently Shared on June 29, 2011 at 8:12 pm By:
Genentech provides update from FDA hearing on medicine for advanced breast cancer http://t.co/f26aDUi
Advertisement
